Icapamespib

N/A

Report date: 2024/12/31 14:55:43
NME

Base Information

Drug NameIcapamespib
Drug Alias NamePU-AD124I-PU-ADPU-HZ151
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsSolid tumoursAmyotrophic Lateral SclerosisAlzheimer Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSamus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSamus Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursAmyotrophic Lateral SclerosisAlzheimer Disease +[7] 

Other Information

ATC CodeN/A
Related LinksN/A